Overview

Apremilast as Anti-pruritic Treatment in Patients With Prurigo Nodularis

Status:
Unknown status
Trial end date:
2019-12-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the anti-pruritic effect of apremilast in patients with known PN.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Tanja Todberg, MD
Treatments:
Antipruritics
Apremilast
Thalidomide